◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksH › HSTM

HealthStream Inc (HSTM) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · HEALTH INFORMATION SERVICES · DATA UPDATED 2026-09-18

HealthStream Inc (HSTM) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in Nashville, United States with about 1,139 employees. Its market capitalization is roughly $894 million. In the fiscal year ended 2025-12-31, HSTM reported $304M in revenue and $18M in net income.

HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.

Interactive charts & full statements → Open the HSTM valuation workbench →

HSTM Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$321M$304M$292M$279M$267M$257M$245M$254M$232M$248M$226M$209M$171M$132M$104M$82M$66M$57M$52M$44M$32M
Gross Profit$209M$197M$194M$184M$176M$166M$155M$150M$136M$142M$129M$120M$97M$77M$62M$51M$42M$36M$32M$28M$21M
Gross Margin %65.1%64.7%66.4%66.0%65.8%64.5%63.5%59.1%58.6%57.2%57.2%57.2%56.6%58.0%59.8%62.2%63.2%62.8%61.9%63.2%65.8%
Operating Income (EBIT)$26M$20M$21M$16M$12M$8M$16M$15M$15M$10M$6M$14M$16M$15M$13M$11M$7M$5M$2M$2M$2M
Operating Margin %8.0%6.7%7.3%5.7%4.7%3.1%6.5%5.8%6.7%4.0%2.5%6.5%9.6%11.1%13.0%13.8%10.7%8.9%4.8%4.4%6.0%
Net Income$21M$18M$20M$15M$12M$6M$14M$16M$32M$10M$4M$9M$10M$8M$8M$7M$4M$14M$3M$4M$2M
Net Margin %6.6%6.0%6.9%5.5%4.5%2.3%5.8%6.2%13.9%4.0%1.7%4.1%6.1%6.4%7.4%8.5%6.3%24.3%5.5%9.3%7.9%
EBITDA$72M$67M$66M$60M$54M$45M$46M$43M$40M$33M$28M$31M$27M$23M$20M$17M$12M$10M$7M$6M$5M
Earnings Per Share (EPS)$0.72$0.61$0.66$0.50$0.39$0.18$0.44$0.49$1.00$0.31$0.12$0.28$0.37$0.30$0.28$0.29$0.18$0.64$0.13$0.18$0.11
Shares Outstanding (M)29M30M31M31M31M32M32M32M32M32M32M30M28M28M28M24M22M22M22M23M22M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HSTM Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$84M$81M$80M$76M$74M$73M$74M$73M
Gross Profit$55M$53M$51M$50M$48M$48M$49M$49M
Gross Margin %65.3%65.8%63.8%65.3%64.6%65.3%66.2%66.5%
Operating Income (EBIT)$8M$8M$2M$8M$6M$4M$5M$6M
Operating Margin %9.9%9.2%3.0%9.9%7.9%6.0%6.3%8.9%
Net Income$7M$6M$3M$6M$5M$4M$5M$6M
Net Margin %8.0%7.3%3.2%8.0%7.2%5.9%6.6%7.8%
EBITDA$20M$19M$14M$19M$18M$16M$16M$18M
Earnings Per Share (EPS)$0.23$0.20$0.09$0.20$0.18$0.14$0.16$0.19
Shares Outstanding (M)29M29M30M30M30M31M31M31M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HSTM Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$72M$63M$58M$64M$51M$42M$36M$66M$43M$47M$24M$35M$34M$26M$23M$20M$16M$12M$6M$7M$4M
Capital Expenditures (CapEx)$23M$4M$28M$2M$2M$25M$19M$37M$18M$18M$15M$15M$10M$9M$9M$10M$5M$3M$2M$4M$4M
Free Cash Flow (FCF)$49M$60M$30M$62M$49M$17M$17M$29M$25M$29M$9M$20M$24M$18M$14M$10M$11M$8M$4M$3M$0M
FCF Margin %15.2%19.6%10.1%22.1%18.5%6.6%7.0%11.5%10.7%11.6%4.2%9.4%14.1%13.3%13.3%11.7%17.4%14.8%7.6%7.4%1.0%
Dividends Paid$4M$4M$3M$3M$2M$0M$0M$0M$32M$0M$0M$0M$0M$0M$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HSTM Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$13M$27M$13M$18M$5M$27M$11M$19M
Capital Expenditures (CapEx)$15M$7M$0M$0M$2M$1M$0M$7M
Free Cash Flow (FCF)($2M)$20M$13M$18M$3M$26M$11M$12M
FCF Margin %-2.1%24.2%16.3%23.4%3.6%35.4%14.8%16.8%
Dividends Paid$1M$1M$1M$1M$1M$1M$1M$1M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HSTM Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$522M$520M$511M$500M$498M$487M$500M$490M$440M$411M$396M$380M$257M$213M$175M$154M$82M$71M$53M$53M$41M
Cash & Cash Equivalents$46M$36M$59M$40M$46M$47M$37M$132M$134M$85M$50M$82M$82M$60M$41M$77M$18M$12M$4M$4M$11M
Total Liabilities$165M$166M$151M$159M$164M$148M$166M$151M$121M$111M$110M$99M$89M$63M$42M$33M$25M$19M$16M$18M$11M
Total Debt (Short + Long-Term)$0M$0M$3M$3M$3M$21M$29M$35M$32M$27M$23M$19M$19M$16M$11M$0M$0M$1M$745M$2M$0M
Total Shareholders' Equity$357M$354M$359M$341M$334M$339M$334M$338M$319M$300M$286M$280M$168M$149M$132M$121M$57M$52M$37M$36M$30M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HSTM viewer.

Other Companies in HEALTH INFORMATION SERVICES

← HSTCAll “H” companiesHSUK →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.